Cargando…
Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis balance towards the procoagulant and antifibrinolytic activity. Several studies have suggested an increased risk of venous thromboembolism in IPF. The ass...
Autores principales: | Sobiecka, Małgorzata, Szturmowicz, Monika, Lewandowska, Katarzyna, Kowalik, Agata, Łyżwa, Ewa, Zimna, Katarzyna, Barańska, Inga, Jakubowska, Lilia, Kuś, Jan, Langfort, Renata, Tomkowski, Witold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684138/ https://www.ncbi.nlm.nih.gov/pubmed/34920701 http://dx.doi.org/10.1186/s12890-021-01794-y |
Ejemplares similares
-
Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Sobiecka, Małgorzata, et al.
Publicado: (2023) -
Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis
por: Lewandowska, Katarzyna B., et al.
Publicado: (2022) -
New 6-Minute-Walking Test Parameter—Distance/Desaturation Index (DDI) Correctly Diagnoses Short-Term Response to Immunomodulatory Therapy in Hypersensitivity Pneumonitis
por: Lewandowska, Katarzyna B., et al.
Publicado: (2023) -
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis
por: Dybowska, Małgorzata, et al.
Publicado: (2022) -
An Unfavorable Outcome of M. chimaera Infection in Patient with Silicosis
por: Łyżwa, Ewa, et al.
Publicado: (2022)